Here, we examined whether anti-GARP:TGF-β1 mAbs could perturb innate or adaptive immune responses at mucosal barriers, using oral gavage of C. rodentium in WT or highly susceptible Il22r−/− mice as a model of intestinal bacterial infection. Here, TGFB1 is linked to intestinal disorder.